The acquisition of the leading manufacturer of plastic containers for prescription drugs in the USA is the biggest take-over in the company’s history.
The company regroups its operations into three divisions: Plastics & Devices, Primary Packaging Glass and Life Science Research
A majority shareholding is acquired in Triveni, a leading manufacturer of pharmaceutical plastic packaging products and closures in India.
Rainer Beaujean is appointed to the Management Board and assumes the function of Chief Financial Officer on Feb. 1, 2013.
Gerresheimer takes over the majority of shares in the Indian company, which manufactures glass pharmaceutical vials.
The Medical Plastic Systems Division is further enlarged by the take-over of Münster-based item GmbH.
Gerresheimer acquires the Brazilian pharmaceutical plastic packaging manufacturer.
Uwe Röhrhoff is appointed as the new CEO.
Gerresheimer opens a new research and development center for medical plastics systems in Peachtree City (Georgia, USA).
Andreas Schütte joins the Management Board.
The Gerresheimer AG share is included in the MDAX index.
Gerresheimer AG is stock exchange listed and the owner, Blackstone, withdrew completely in a two-step process.
The German market and technology leader for medical plastic systems is taken over by Gerresheimer Regensburg GmbH.
The company headquarters moves from the Düsseldorf district of Gerresheim to another location in Düsseldorf.